CLDF Title
Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
Banner4 Banner2 Banner3
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
Nonalcoholic fatty liver disease linked to procoagulant imbalance
04-02-2014
Costs to public of $84,000 hep C drug 'outrageous' - Kaiser
04-02-2014
Gilead says has discounted hepatitis C drug for some health plans
03-31-2014
Glycerol phenylbutyrate improves hepatic encephalopathy outcomes
03-28-2014
View Complete News Library
 
 
June 4-7
20th Annual International Congress Of The International Liver Transplantation Society (ILTS)
London, UK
June 6-7
GALA (GI and Liver Association of the Americas) Conference
Dallas, Texas
June 9-12
47th Annual Meeting- The European Society For Pediatric Gastroenterolgy, Hepatology & Nutrition (ESPGHAN)
Jerusalem, Israel
July 26-31
American Transplant Congress
San Francisco, California
View all Congresses
 
 
 
 
  Line  
  Featured Abstracts          
 
Second wave Anti-HCV Protease Inhibitors: Too little too late?
 
The Effect of Mild to Moderate Renal Impairment on the Pharmacokinetics of the Nucleoside Analog Hepatitis C Virus Polymerase Inhibitor Mericitabine
 
Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 12188)
 
Fracture risk in hepatitis C virus infected persons: results from the DANVIR cohort study
 
Barriers to HCV treatment in the era of triple therapy: A prospective multi-centered study in clinical practice
 
Hepatitis C treatment: an incipient therapeutic revolution
 
 
Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
 
Hepatitis B in pregnancy
 
Management of hepatitis B during pregnancy
 
Prevention of Neonatal Hepatitis B Virus Transmission
 
Survival in infection-related acute-on-chronic liver failure is defined by extra-hepatic organ failures
 
Cerebral Hemodynamics In Cirrhotic Patients With Hepatic Encephalopathy
 
 
Management of hyponatremia in clinical hepatology practice
 
Branched-chain amino acid supplementation in adults with cirrhosis and porto-systemic encephalopathy: Systematic review
 
Combination Therapy of Sorafenib and TACE for Unresectable HCC: A Systematic Review and Meta-Analysis
 
Alternative Response Criteria (Choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib
 
Improved Survival Outcomes in Patients with Nonalcoholic Steatohepatitis and Alcoholic Liver Disease Following Liver Transplantation: An Analysis of 2002-2012 UNOS Data
 
Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients
 
 
          View All Abstracts  
  Line  
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
CME Dinner Meeting
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.